Insights into targeting SARS-CoV-2: design, synthesis,in silicostudies and antiviral evaluation of new dimethylxanthine derivatives
- 21 March 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (5) , 899-920
Abstract
The expanded structure- and ligand-based drug design strategy was utilized to obtain a multitargeting SARS-CoV-2 inhibitor, compound 9a, with an IC50value of 8.86 μM.Keywords
This publication has 75 references indexed in Scilit:
- 3-Chloro-N-(4-sulfamoylphenyl)propanamideActa Crystallographica Section E Crystallographic Communications, 2010
- 2-Chloro-N-(4-fluorophenyl)acetamideActa Crystallographica Section E Structure Reports Online, 2008
- The purines: Potent and versatile small molecule inhibitors and modulators of key biological targetsBioorganic & Medicinal Chemistry, 2006
- Effective handling of induced‐fit motion in flexible dockingProteins: Structure, Function, and Bioinformatics, 2006
- Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivativesBioorganic & Medicinal Chemistry, 2004
- Improved antiviral activity of the aryloxymethoxyalaninyl phosphoramidate (APA) prodrug of abacavir (ABC) is due to the formation of markedly increased carbovir 5′‐triphosphate metabolite levelsFEBS Letters, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonistsBioorganic & Medicinal Chemistry, 2004
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Molecular dynamics with coupling to an external bathThe Journal of Chemical Physics, 1984